Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development
04.December 2008 08:00 CET
- AC Immune selected as Technology Pioneer 2009 by the Word Economic Forum
- Phase II clinical trial for small molecule ACI-91 approved
- First patient enrolled in phase I study of Anti-Abeta antibody - Milestone payment received from collaborator Genentech